Trading a DYN straddle lets you take a pure volatility position on Dyne Therapeutics Inc without committing to a direction. Dyne Therapeutics Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate DYN straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on DYN profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Dyne Therapeutics Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the DYN straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..
Earnings, product cycles, macro prints — any time volatility itself is the trade, the DYN straddle is the cleanest expression of that view. Our scanner prices every DYN straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a DYN straddle into a catalyst or short a DYN straddle to harvest decay, the options straddle setups that matter are all in one place.
